Status: Recruiting
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
This phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells. A shorter duration of radiation treatment may avoid some of the delayed side effects of radiation while providing a more convenient treatment and reducing costs.
Participants needed: 70
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Emory UniversityUpdated: Feb 17, 2026Locations: 1
Eligibility criteria
Pathologically or radiographically diagnosed benign intracranial or nerve sheath... [+2]
Pregnant females are excluded. Female of child-bearing potential (FCBP) must hav... [+3]